Cannabis Law Report

AUGUST 22, 2021

The addition of methylated tryptamines with pending patent protection is focused on the potential improvement of treatments for mental health conditions including depression, anxiety and addiction, as well as other psychological and neurologic conditions. ” About PsyBio Therapeutics Corp.

Clinical Trials 98

Clinical Trials Research and Development Treatment Conditions 98

Cannabis Law Report

JUNE 30, 2021

In addition, the company aims to predict what treatments are most effective in addressing these conditions, including psychedelics, which have shown tremendous promise in early clinical trials. For more information, visit the company’s website or download their investor presentation. MedXtractor Corp.’s Looking Ahead.

Treatment 52

Treatment Clinical Trials Research and Development Data 52

The Cannigma

MARCH 7, 2022

Therefore, it makes sense that CBN is most commonly found in aged or improperly stored cannabis, and hardly ever present in fresh flower or low-temp extractions. What can the current clinical trials tell us? Those enrolled in the study will receive 28 days of treatment and then be assessed by pain-rating scales.

THC 139

THC Sleep Clinical Trials Cannabinoids 139

CannaMD

JUNE 2, 2021

In a paper presented at the 2020 International Congress of Parkinson’s Disease and Movement Disorders , the authors reported on the results of an anonymous survey completed by more than 1,000 individuals living with Parkinson’s disease.

Patients 105

Patients Clinical Trials Treatment Research and Development 105

MMJ Recs

JULY 9, 2024

Traditional treatments, while helpful to some extent, often come with limitations and side effects that can further burden individuals already dealing with a debilitating disease. Medical marijuana has emerged as a promising alternative treatment option for managing symptoms associated with MS.

Marijuana 111

Marijuana Treatment Cannabinoids Patients 111

Veriheal

JANUARY 28, 2022

The cannabis compound cannabidivarin (CBDV) has already been found to be a promising treatment for ASD, particularly in terms of repetitive behaviors, irritability, social functioning, and inflammation. Children with ASD can still benefit from cannabis oil containing THC as long as the quantity is low but present.

Oil 104

Oil THC Research and Development Treatment 104

Veriheal

JULY 16, 2020

The commission tasked with developing recommendations to improve mental health treatment for veterans concluded: Congress and the executive branch need to promote research into the therapeutic potential of cannabis and psychedelics such as psilocybin mushrooms and MDMA. Research is Limited Due to Many Obstacles.

Research and Development 97

Research and Development Clinical Trials Treatment Compliance 97

Canna Care Docs

JUNE 18, 2018

CBD is one of close to 85 cannabinoids present in cannabis, with THC being the most commonly known. With increased attention and further legalization efforts in the United States, research surrounding the health applications are still in its infancy stages, but documentation and clinical trials continue to flow into the public sphere.

Clinical Trials 75

Clinical Trials CBD Epilepsy Patients 75

The Cannigma

FEBRUARY 2, 2021

In light of these results, the researchers behind the survey say that physicians should pay special consideration to these aspects when advising patients on their medical cannabis treatment options. Physicians should consider these aspects when advising their patients about treatment with medicinal cannabis. Still, research is ongoing.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

Veriheal

MAY 16, 2022

Researchers working at the University of Arizona College of Medicine in Tucson have refined a method of ketamine use in the treatment of Parkinson’s disease (PD). Specifically, the group focused on ketamine’s ability to relieve the side effects of a common treatment called Levodopa.

Research and Development 19

Research and Development Treatment Clinical Trials Patients 19

Cannabis Law Report

JULY 24, 2021

The groundbreaking progress that we’ve seen from the Multidisciplinary Association for Psychedelic Studies (MAPS) in its Phase 3 clinical trials of MDMA-assisted psychotherapy for Post-Traumatic Stress Disorder (PTSD), including receiving Breakthrough Therapy Designation from the Food and Drug Administration (FDA), shows great promise to date.

Research and Development 105

Research and Development Clinical Trials Therapy Events 105

Cannabis Law Report

AUGUST 12, 2021

Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021. This is the largest trial ever conducted in psilocybin therapy, and it was done amid the lockdowns and challenges of the COVID pandemic. million, or $0.79 million, or $2.61

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

MMJ Recs

JULY 11, 2024

Medical marijuana is a potential treatment for insomnia, and it offers an alternative to traditional pharmaceuticals. Chronic insomnia often requires a more comprehensive treatment approach. It not only impacts mental and physical health but also diminishes quality of life by affecting concentration, mood, and overall productivity.

Sleep 111

Sleep Treatment Research and Development Therapy 111

Veriheal

OCTOBER 13, 2020

Cannabis has been identified as an effective alternative treatment for some gastrointestinal disorders…but does that include IBD and IBS? . Diet is used as the primary treatment. . Dronabinol is commonly used as a treatment in cancer patients due to the fact that it can decrease gut transit and increase colon compliance.

Digestion 124

Digestion Treatment Conditions Research and Development 124

Otherside Farms

JANUARY 25, 2019

Lead author Dr. Tim England, honorary consultant stroke physician at the University of Nottingham and Royal Derby Hospital, presented the findings at this week’s annual UK Stroke Forum conference. The data are guiding the next steps in experimental stroke in order to be able to progress onto initial safety assessments in a clinical trial.”.

Clinical Trials 74

Clinical Trials Marijuana Cannabinoids Data 74

Cannabis Law Report

JUNE 11, 2021

This chief executive officer transition is a natural progression for MindMed as the Company heads into later stage clinical trials. Our work to date and ability to raise capital has taken us leaps and bounds closer to that vision. This all could not have been possible without you.”.

Clinical Trials 95

Clinical Trials Research and Development Pharmaceutical Medicine 95

Puff Puff Post

OCTOBER 3, 2019

Not only did the success influence the European Commission to approve Epidoliolex , but it also sparked motivation to develop a similar treatment for other disorders. Dr. Alexander Kolevzon, clinical director of the Seaver Autism Center at Mount Sinai, is skeptical due to the wide range of symptoms that are present on the autism spectrum.

Research and Development 94

Research and Development Epilepsy Clinical Trials Treatment 94

Cannabis Law Report

DECEMBER 3, 2021

We are honored to be at the AES Meeting this year after almost a year of planning from our medical and scientific affairs, clinical, and advocacy teams, with nine presentations spanning our IV and oral portfolio—Marinus’ largest data showing to date,” said Scott Braunstein, M.D., Chief Executive Officer of Marinus Pharmaceuticals. “We

Epilepsy 40

Epilepsy Pharmaceutical Data Clinical Trials 40

CannaMD

AUGUST 26, 2020

Current Cocaine Treatments. As researchers point out: There is no gold standard pharmacological treatment for dependence on cocaine. Although several drugs have been investigated, there is no strong or consistent evidence indicating any of these drugs for the treatment of cocaine use disorder. mice/rats).

Therapy 98

Therapy CBD Research and Development Treatment 98

Cannabis Law Report

OCTOBER 15, 2021

At ASHG, Goldfinch Bio will give an oral presentation showcasing insights revealed by its Kidney Genome Atlas (KGA). The presentation details the identification of a novel locus on chromosome 14 which is associated with proteinuric kidney disease and includes data which confirms the well-known association of APOL1 risk haplotypes (i.e.,

Clinical Trials 40

Clinical Trials Research and Development Data Patients 40

MMJ Recs

NOVEMBER 20, 2023

Epilepsy Management: CBD, in particular, has emerged as an effective treatment for epilepsy, especially in individuals with rare and severe forms of the condition. Neurological Disorders: Several cannabinoids show promise in the treatment of neurological disorders, including multiple sclerosis (MS) and Parkinson’s disease.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

Cannabis Law Report

JUNE 8, 2021

This SRA will leverage four other clinical trials being planned by the university, to determine the effects of psilocybin on inflammatory markers of patients who have exhibited Parkinson’s, Bipolar disorder, and chronic back pain. The goal at TrPR is to accelerate progress towards impactful and accessible psychedelic treatments.

Patients 70

Patients Research and Development Clinical Trials Chronic Pain 70

Cannabis Law Report

SEPTEMBER 22, 2021

Investors are invited to view the presentation and the panel here: link. Can-Fite Corporate Presentation. The Company’s lead drug candidate, Piclidenoson, is currently in a Phase III trial for psoriasis and a Phase II study in the treatment of moderate COVID-19. Details are below: Medical Cannabis Panel.

Clinical Trials 40

Clinical Trials Treatment Business Events 40

Veriheal

NOVEMBER 17, 2020

But this has failed in the past and could prevent measures from moving forward this time unless new research could be presented to sway the state medical board’s decision. He ran clinical trials for big pharma’s GW Pharmaceuticals research division on Epidiolex. Anup Patel is the most perplexing.

Conditions 98

Conditions Research and Development Pharmaceutical Clinical Trials 98

420 Insight

JULY 25, 2015

Chronic pain persists over a long period of time and is resistant to most medical treatments. If you are suffering from chronic pain, you may experience greater relief if your doctors add cannabinoids – the main ingredient in cannabis or medical marijuana – to an opiates-only treatment.

Chronic Pain 75

Chronic Pain Nerve Pain Clinical Trials Sleep 75

PrestoDoctor

SEPTEMBER 15, 2023

While there are a variety of treatments available, many individuals do not find relief with traditional medications or therapies. It is a serious medical condition that requires appropriate treatment and support. Furthermore, conventional treatments often focus on symptom management rather than addressing the root causes of OCD.

Research and Development 105

Research and Development Therapy Treatment Strains 105

Cannabis Law Report

JANUARY 26, 2022

MDMA as an adjunct to therapy for PTSD is the forty-first treatment to receive the Innovation Passport since its inception in January 2021. The designation is intended to accelerate the timeline for approval of innovative medicines for treatment of life-threatening conditions or those which present a significant patient or public health need.

Therapy 52

Therapy Clinical Trials Research and Development Treatment 52

Cannabis Law Report

NOVEMBER 1, 2021

The Liver Meeting, which takes place virtually on November 12 – 15, 2021, brings together clinicians, associates, and scientists from around the world to exchange information on the latest research, discuss new developments in liver treatment and transplantation, and network with leading experts in the field of hepatology.

Clinical Trials 40

Clinical Trials Research and Development Treatment Business 40

CannaMD

NOVEMBER 8, 2019

VA providers can and do discuss marijuana use with veterans as part of comprehensive care planning, and adjust treatment plans as necessary. VA health care providers will record marijuana use in the veteran’s VA medical record in order to have the information available in treatment planning. VidaCann : 15% discount.

Marijuana 85

Marijuana Treatment Research and Development Patients 85

Cannabis Law Report

MAY 31, 2022

The only psychedelic drug that is approved (outside of clinical trials) for psychiatric use—as opposed to anesthesia—through the traditional medical system is Ketamine. Food and Drug Administration (FDA) approved esketamine (a component of Ketamine and sold under the brand name Spravato) for treatment-resistant depression.

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

The Joint Blog

APRIL 21, 2020

This is according to a study published in the Journal of Clinical Medicine Research and epublished by the U.S. For the study researchers with the Nordic Cannabis Research Institute in Denmark reviewed 25 clinical trials assessing the safety and efficacy of CBD in various populations. National Institute of Health.

Clinical Trials 52

Clinical Trials CBD Safety Patients 52

Cannabis Law Report

NOVEMBER 23, 2021

The new patent, US Patent No 11,180,517, covers methods of treating treatment-resistant depression (TRD) with crystalline psilocybin as well as with oral dosage forms of crystalline psilocybin with an excipient. This is COMPASS’s 10 th patent overall, with five now granted in the US, two in the UK, one in Germany and two in Hong Kong.

Clinical Trials 52

Clinical Trials Therapy Research and Development Media 52

Cannabis Law Report

NOVEMBER 19, 2021

MAPS PBC is pioneering a new form of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for PTSD. MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD. Key Responsibilities.

Clinical Trials 52

Clinical Trials Research and Development Therapy Compliance 52

MMJ Recs

JULY 17, 2024

Chemotherapy remains a cornerstone in cancer treatment, yet its effectiveness often comes at a significant cost to patients. The side effects can be debilitating, impacting quality of life and treatment adherence. Medical Marijuana: Understanding the Basics What is Medical Marijuana?

Marijuana 52

Marijuana Treatment Patients Therapy 52

Puff Puff Post

JANUARY 13, 2020

These combinations cause the cannabidiol to have different effects, depending on what amounts they are present in the CBD oil. Pharmacies, as more profitable companies, have the resources to research the other cannabinoids present in CBD oil. Cannabidiol As Treatment For Opiate and Alcohol Addiction. Physicians at Mt.

CBD 52

CBD Clinical Trials Research and Development Oil 52

Puff Puff Post

JANUARY 13, 2020

These combinations cause the cannabidiol to have different effects, depending on what amounts they are present in the CBD oil. Pharmacies, as more profitable companies, have the resources to research the other cannabinoids present in CBD oil. Cannabidiol As Treatment For Opiate and Alcohol Addiction. Physicians at Mt.

CBD 52

CBD Clinical Trials Research and Development Oil 52

The Joint Blog

JANUARY 31, 2021

The study states that the individual saw drastic improvements after six-months of treatment, saying he retained “positive effects on his behavioral symptoms, anxiety, sleep, and social deficits” since then. The primary reasons for use in our patient population was treatment of aggressive (including self-injurious behaviors) and epilepsy.

Epilepsy 62

Epilepsy Extraction Research and Development Clinical Trials 62